| Name | Barron Center |
|---|---|
| Location | 1145 Brighton Ave, Portland, Maine |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 219 |
| Occupancy Rate | 61.05% |
| Medicare ID (CCN) | 205011 |
| Legal Business Name | City Of Portland |
| Ownership Type | Government - City |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Arterial stiffening has long been considered a major risk factor for cardiovascular disease. Keeping arteries soft and supple might reduce disease risk, but the mechanisms of how arteries stave off hardening has remained elusive.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food. A team from the Children's Hospital of Eastern Ontario (CHEO) Research Institute has identified a protein that inhibits insulin production in mice - work that offers a new way of understanding, and perhaps of one day treating, both Type 1 and Type 2 diabetes.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.97 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.9 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.36 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.51 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.33 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 7.74 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.17 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.6 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.71 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.77 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.35 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 9.09 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 42.56 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.72 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.38 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.41 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 74.38 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 87.79 | 82.93 |
News Archive
Arterial stiffening has long been considered a major risk factor for cardiovascular disease. Keeping arteries soft and supple might reduce disease risk, but the mechanisms of how arteries stave off hardening has remained elusive.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food. A team from the Children's Hospital of Eastern Ontario (CHEO) Research Institute has identified a protein that inhibits insulin production in mice - work that offers a new way of understanding, and perhaps of one day treating, both Type 1 and Type 2 diabetes.
› Verified 5 days ago
Seaside Rehab & Health Care Location: 850 Baxter Boulevard, Portland, Maine 04103 Phone: (207) 774-7878 | |
St Joseph's Rehabilitation And Residence Location: 1133 Washington Ave, Portland, Maine 04103 Phone: (207) 797-0600 |